Insights From Our Labs to Yours Labcorp Drug Development Blog Navigation Home Industry Device Drug Chemical Crop Phase Discovery Preclinical/Nonclinical Phase I-IIa Phase IIb-III Pilot Pivotal Formulation, Packaging, etc. Molecule Type Biologics Small Molecules Biosimilars Biomarkers Cell/Gene Therapies Data/Informatics SEND Modeling Patient Recruitment Xcellerate About Us Careers and Culture Contact Us Covance.com Search for: A Creative Solution to Address the Biosimilar Boom Decentralized Clinical Trials (DCT) Monthly Blog – May 2021 Covance by Labcorp Expanding Bioanalytical Service Offering in Asia Pacific with Integrated Laboratory in Singapore Share Five Benefits of Risk-Based Quality Management (RBQM) for Clinical Trial Data by Daniel Kowalski, Senior Informatics Manager, Covance by Labcorpupdated on Thursday, June 3, 2021Monday, May 3, 2021 Risk-based quality management methodologies address risk control and management during execution of a clinical trial. RBQM adoption has generated valuable benefits for project management and clinical operations, changing the way trial monitoring is done. However, data management activities are ideally suited for an RBQM approach as well. Today, we explore … Share Webinar: Advancing Your Neurodegenerative Biomarker Strategy Beyond Discovery by Covance by Labcorpupdated on Tuesday, June 8, 2021Monday, May 3, 2021 On April 15, we hosted the virtual conference, “Advancing Your Neurodegenerative Biomarker Strategy Beyond Discovery.” For study teams working to develop treatments for patients suffering from neurodegenerative diseases, the need to leverage new techniques quickly and effectively is imperative. This topic is vital, as nearly 50 million people worldwide suffer … Share Welcome to the April edition of our Decentralized Clinical Trials blog by Dr. Marc Goldstein, Marketing Strategy Director, Covance Decentralized Clinical Trialsupdated on Thursday, June 3, 2021Friday, April 30, 2021 Sometimes success isn’t about the pieces that you have at your disposal, but rather it comes from how these pieces connect to each other, transforming a process and leading to a better outcome. Share Antibody Reagent Spotlight – Generating positive control antibodies for your Anti-Drug Antibody (ADA) assay by Murty Chengalvala PhD, Director of Science, Antibody Reagents and Vaccinesupdated on Thursday, June 3, 2021Thursday, April 29, 2021 Biotherapeutics have been on the center stage in the pharmaceutical industry portfolios and accounted for almost one-half of recent new drug approvals. The majority of these products are monoclonal antibodies (mAbs), recombinant proteins, hormones, cytokines, growth factors, gene therapy products and gene-silencing/editing therapies. The potential immunogenicity of biological products results … Share Recognizing National Kidney Month by Breaking Down Barriers to Improve Clinical Trials for Glomerular Diseases by Barbara S. Gillespie, MD, MMS, FASNupdated on Thursday, June 3, 2021Monday, April 12, 2021 To raise awareness about kidney diseases during National Kidney Month, we’d like to focus on rare renal diseases and the importance of studying not only adults but the pediatric population as well. Several rare glomerular diseases1 can impact the kidney’s important cleansing function. Tiny clusters of looping blood vessels, called … Share Decentralized Clinical Trials (DCT) Monthly Blog – March 2021 by Covance by Labcorpupdated on Thursday, June 3, 2021Monday, March 29, 2021 This month, we want to highlight the growing connections between decentralized clinical trials (DCTs) and the critical therapeutic area of oncology. Share Expanding clinical trial support in Europe, the Middle East and Africa with a new automated kit production line by Covance by Labcorpupdated on Tuesday, June 8, 2021Friday, March 26, 2021 As part of a global growth and expansion strategy, we’re announcing the spring opening of a new kit production line at our European Operations Center (EOC). Based in Mechelen, Belgium, the EOC is a multi-use facility that handles dry ice production and distribution for the EU, as well as study … Share Covance by Labcorp Announces Plans for New Clinical Pharmacology Site in Leeds, UK by Covance by Labcorpupdated on Thursday, June 3, 2021Tuesday, March 23, 2021 Work is underway to transform an existing building in the heart of Leeds’s Temple district into a fit-for-purpose facility that will raise the bar for clinical conduct and volunteer engagement. The new site will consolidate our two existing central Leeds locations into one facility just minutes away from hospitals and … Share Minimal Residual Disease by Flow Cytometry: Latest Insights on Validation by Covance by Labcorpupdated on Tuesday, June 8, 2021Monday, March 22, 2021 Despite the development of cellular and antibody-based therapeutics that eliminate malignant cells, patients who have achieved complete remission or response may experience relapse. Increasing evidence suggests that the presence of measurable/minimal residual disease (MRD) in bone marrow (BM) tissue is one, if not the strongest, prognostic factor for disease outcome … Share Quantitative Whole Body Autoradiography (QWBA): Your Questions Answered by Covance by Labcorpupdated on Thursday, June 3, 2021Monday, March 22, 2021 QWBA helps characterize the distribution of a drug within the body and provides vital metabolic information to inform your preclinical drug development program. Here we gain advice from two experienced study leaders on common QWBA questions and challenges. Languages: 简体中文 Français Deutsch 日本語 Español English Category About Us (1) Analytical Services (3) Antibodies (1) Autoimmune/Inflammatory (11) Biologics (13) Biomarkers (11) Biosimilars (4) Cardiology (3) Cell/Gene Therapies (5) Chemical (15) Clinical Development (45) Clinical Testing (12) CNS (1) Commercialization (10) Consulting (3) Crop (13) Data/Informatics (15) Decentralized Clinical Trials (11) Device (14) Discovery (6) Drug (182) Formulation, Packaging, etc. (1) General Medicine (2) Health Economics & Market Access (5) Healthcare (1) Immunology (2) Industry (1) Infectious Disease (3) Inhalation (1) Lead Optimization (7) Manufacturing Support (1) Metabolic/Endocrine (11) Metabolism & PK (4) NASH (6) Nephrology (1) Oncology (37) Pathology (1) Patient Recruitment (9) Pediatrics (2) Phase I-IIa (19) Phase IIb-III (78) Pilot (3) Pivotal (10) Preclinical/Nonclinical (101) Pulmonary/Respiratory (5) Rare Disease (8) Regulatory Agencies (2) Regulatory Milestones (1) Renal/Hepatic (2) Reproductive Health (1) Risk Management (4) Routes (1) Safety (3) Safety Assessment (9) SEND (7) Small Molecules (7) Technology Services (2) Uncategorized (2) Vaccine (4) Vaccine (2) Xcellerate (7) Archives Archives Select Month June 2021 May 2021 April 2021 March 2021 February 2021 January 2021 December 2020 November 2020 October 2020 September 2020 August 2020 July 2020 June 2020 May 2020 April 2020 March 2020 February 2020 January 2020 December 2019 October 2019 September 2019 August 2019 May 2019 April 2019 March 2019 February 2019 January 2019 December 2018 November 2018 October 2018 September 2018 August 2018 July 2018 June 2018 May 2018 March 2018 February 2018 January 2018 November 2017 October 2017 September 2017 August 2017 July 2017 June 2017 May 2017 April 2017 March 2017 February 2017 January 2017 December 2016 November 2016 September 2016 August 2016 July 2016 June 2016 May 2016 April 2016 March 2016 February 2016 January 2016 November 2015 August 2015 June 2015 March 2015 Tags biologics Biomarkers biosimilars cancer CDx central laboratory services China Clinical Development clinical trials CMC commercialization Companion Diagnostics COVID-19 CRO Crop Protection dart data management Decentralized Clinical Trials (DCT) Decentralized Trials Diabetes Diabetic Kidney Disease Drug Development Drug Safety FDA Flow Cytometry Immuno-Oncology informatics LabCorp Market Access medical device NAFLD NASH Patient Centricity Patient Recruitment Pharmacovigilance precision medicine Rare Diseases REACH Real-World Evidence Regulatory Rheumatoid Arthritis send Vaccine Development vaccines Xcellerate Copyright © 2020 Covance Inc. All rights reserved. TOP